These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26678875)

  • 1. Architecture of human mTOR complex 1.
    Aylett CH; Sauer E; Imseng S; Boehringer D; Hall MN; Ban N; Maier T
    Science; 2016 Jan; 351(6268):48-52. PubMed ID: 26678875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights of mTOR complex 1.
    Yuan HX; Guan KL
    Cell Res; 2016 Mar; 26(3):267-8. PubMed ID: 26794870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4.4 Å Resolution Cryo-EM structure of human mTOR Complex 1.
    Yang H; Wang J; Liu M; Chen X; Huang M; Tan D; Dong MQ; Wong CC; Wang J; Xu Y; Wang HW
    Protein Cell; 2016 Dec; 7(12):878-887. PubMed ID: 27909983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tor forms a dimer through an N-terminal helical solenoid with a complex topology.
    Baretić D; Berndt A; Ohashi Y; Johnson CM; Williams RL
    Nat Commun; 2016 Apr; 7():11016. PubMed ID: 27072897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CELL SIGNALING. Seeing mTORC1 specificity.
    Buel GR; Blenis J
    Science; 2016 Jan; 351(6268):25-6. PubMed ID: 26721988
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40.
    Yang H; Jiang X; Li B; Yang HJ; Miller M; Yang A; Dhar A; Pavletich NP
    Nature; 2017 Dec; 552(7685):368-373. PubMed ID: 29236692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR-what does it do?
    Hall MN
    Transplant Proc; 2008 Dec; 40(10 Suppl):S5-8. PubMed ID: 19100909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the human mTOR complex I and its implications for rapamycin inhibition.
    Yip CK; Murata K; Walz T; Sabatini DM; Kang SA
    Mol Cell; 2010 Jun; 38(5):768-74. PubMed ID: 20542007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR kinase structure, mechanism and regulation.
    Yang H; Rudge DG; Koos JD; Vaidialingam B; Yang HJ; Pavletich NP
    Nature; 2013 May; 497(7448):217-23. PubMed ID: 23636326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes.
    Tao Z; Barker J; Shi SD; Gehring M; Sun S
    Biochemistry; 2010 Oct; 49(39):8488-98. PubMed ID: 20804212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIKKs--the solenoid nest where partners and kinases meet.
    Baretić D; Williams RL
    Curr Opin Struct Biol; 2014 Dec; 29():134-42. PubMed ID: 25460276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TORC2 Structure and Function.
    Gaubitz C; Prouteau M; Kusmider B; Loewith R
    Trends Biochem Sci; 2016 Jun; 41(6):532-545. PubMed ID: 27161823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionarily conserved regulation of TOR signalling.
    Takahara T; Maeda T
    J Biochem; 2013 Jul; 154(1):1-10. PubMed ID: 23698095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved sequence motifs and the structure of the mTOR kinase domain.
    Sauer E; Imseng S; Maier T; Hall MN
    Biochem Soc Trans; 2013 Aug; 41(4):889-95. PubMed ID: 23863151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins.
    Inobe T; Nukina N
    J Biosci Bioeng; 2016 Jul; 122(1):40-6. PubMed ID: 26777239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the Domain Arrangement of the Mammalian Target of Rapamycin Complex Component Rictor Protein.
    Zhou P; Zhang N; Nussinov R; Ma B
    J Comput Biol; 2015 Sep; 22(9):876-86. PubMed ID: 26176550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.
    Carrière A; Cargnello M; Julien LA; Gao H; Bonneil E; Thibault P; Roux PP
    Curr Biol; 2008 Sep; 18(17):1269-77. PubMed ID: 18722121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesylthiosalicylic acid inhibits mammalian target of rapamycin (mTOR) activity both in cells and in vitro by promoting dissociation of the mTOR-raptor complex.
    McMahon LP; Yue W; Santen RJ; Lawrence JC
    Mol Endocrinol; 2005 Jan; 19(1):175-83. PubMed ID: 15459249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary conservation of TORC1 components, TOR, Raptor, and LST8, between rice and yeast.
    Maegawa K; Takii R; Ushimaru T; Kozaki A
    Mol Genet Genomics; 2015 Oct; 290(5):2019-30. PubMed ID: 25956502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.